Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001834411-26-000006

Chief Financial Officer acquired 250,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Booth Andrew Chief Financial Officer 2026-06-03 Option exercise +250,000 $0.19 $47,500 445,600 D
Derivatives
Booth Andrew Chief Financial Officer 2026-06-03 Option exercise · Share option (right to buy) −250,000 8,501,849 D
Loading xslF345X06/wk-form4_1780510993.xml…